The United States is right to worry about losing ground to China in clinical research. But if Washington frames trial reform mainly as a race, it risks missing the larger prize: a faster, safer and more trusted model for developing medicines that the rest of the world can rely. The Food and Drug Administration’s (FDA) […] The post To beat China in the lab, America’s edge is trust not speed appeared first on Asia Times .